Belgium onlyRhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases and provide meaningful support for healthcare providers and patients and their families. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.
Opportunity Overview
As the first member of the Rhythm Belgian team, you will be working within the field of rare MC4R pathway diseases. As the Hospital Affairs Lead (HAL), you will own sales responsibility for Rhythm’s lead medicine in Belgium across its approved indications, work collaboratively within the National and International team to lead the sales strategy and serve as a trusted commercial partner to external experts, decision makers and Health Care Professionals (HCP) through scientific expertise, project management, network formation and service offerings.
Responsibilities and Duties
- National sales responsibility for Rhythm’s lead medicine
- Develop strong partnerships with key experts, payers and multidisciplinary stakeholders
- Deliver growth in line with expectations for the Belgian business
- Support development and expansion of comprehensive care programs and Patient Support Programs
- Facilitate referral pathways between peripheral sites and prescribing centers
- Lead an omnichannel customer approach relevant for customer segmentation and individual customer preferences/objectives
- Challenge current practice to deliver the best outcomes for patients
- Able to discuss benefits of clinical data to improve the lives of patients (in line with approved indications), creating strong product advocacy
- Possess thorough knowledge of national policy and public stakeholders to identify opportunities for optimal patient management and revenue growth
- Identify and input into key projects as part of project team, e.g. national meetings
- Collect and share customer and environmental insights to deliver optimal patient management
- Lead or support regional and national conferences and best in class local educational meetings
- Regularly perform market, customer & competitor observation
- Ensure adherence with compliance, ethics, and general law
- Acts as a local customer contact for distribution (i.e. linking pin between customers and Patient Support Program)
- Lead the planning (i.e. account plans), tracking and reporting process for the territory
- Accountable for using CRM system for business planning
Qualifications and Skills
- Academic degree (science or economy), MBA or PhD is a plus
- At least 5 years sales experience in specialty care with a documented tangible track record
- Orphan drugs/Rare Diseases experience recommended
- Experience with building and maintaining strong relationships with key experts and key stakeholders (HCPs, specialist nurses, hospital pharmacists, payors, multi-disciplinary teams)
- Sound experience in facilitating referral pathways
- Experience with successful launches
- Experience and track record in use of IT based/virtual customer interaction and promotional tools
- Experience in site specific project management
- Commercial acumen and financially savvy
- Ability to identify opportunities, manage complexity and priorities and liaise, influence internally to ‘make it happen’ whilst being comfortable working with uncertainty
- Excellent communication and presentation skills - fluent in Dutch and French and in verbal and written English
- Not accepting the status quo, working with a sense of urgency to deliver results
- High integrity, collaborative approach
This role is field-based in Belgium. Candidates applying must be willing and able to travel frequently.
More about Rhythm
Our lead asset, IMCIVREE® (setmelanotide), is a precision medicine designed to treat hyperphagia, an insatiable, pathological hunger characterized by abnormal food-seeking behaviors, and early- or rapid-onset severe obesity caused by an impairment of a pathway in the hypothalamus called the melanocortin-4 receptor (MC4R) pathway. IMCIVREE® is the first and only approved therapy for certain rare MC4R pathway diseases in the United States, Europe, Great Britain and several other countries. In collaboration with leading experts across the world, Rhythm is advancing the most comprehensive clinical research program ever initiated in MC4R pathway diseases, including a Phase 3 trial for acquired hypothalamic obesity. In addition, we are leveraging our extensive genetic database, global network of researchers, a track record of regulatory successes and global commercial infrastructure to develop a full portfolio of treatment options to patients struggling with hyperphagia and severe obesity and ensuring they get the treatment that is right for them. We continue to advance care and precision medicines that address rare diseases. We are focused on expanding access to IMCIVREE® to reach more patients and developing novel therapies for other rare neuroendocrine diseases, including congenital hyperinsulinism. Rhythm’s headquarters is in Boston, MA.
United States only
Colombia only
Argentina only
Canada only